Authors


Gary Kennedy, MD

Latest:

Addressing Psychosomatic Illness in the Elderly: Integrated Care

The need to integrate psychiatric treatment with somatic care puts psychosomatic medicine in a unique position to focus on older patients who would not otherwise seek specialized treatment.


Gary L. Kreps, PhD

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


Gary Patronek, VMD, PhD

Latest:

The Hoarding of Animals: An Update

The authors provide information about the human-animal bond that may provide a starting point for understanding the development of animal-hoarding disorder.


Gaurav Mishra, MD

Latest:

Beyond the Addict: Keeping Countertransference in Check

Medicine is not about making us feel better about ourselves-although this doesn’t hurt. In the case of addicts, it is about looking at the root cause of addictions and seeing the person-not just the addict-in front of us.


Gavin L. Brunsvold, MD

Latest:

Comorbid Depression and ADHD in Children and Adolescents

ADHD, the most common diagnosis in child psychiatry, appears to be more challenging to diagnose and treat when there is a comorbid depressive disorder.


Geetha Senthil, PhD

Latest:

The OPTICS Project: An Open-Science Framework for the Analysis of Clinical Trial Data

A report of initiatives that have raised awareness of and promoted data sharing and data transparency in order to advance science and improve public health and health care.


Gemma Taylor, MSc

Latest:

Quitting Smoking: Therapeutic in Mental Health Treatment

Many patients report that smoking helps them with their stress and psychological disturbances. However, smoking may actually worsen some of these symptoms. When is the right time for your patients to quit?


Gene Usdin, MD

Latest:

Famous Marriages: What They Can Teach Us

This book is recommended not only for therapists but also for patients in therapy and others seeking enjoyable, fascinating reading and insight into their own marital relationships.


Geoffrey D. Carr, PhD

Latest:

Psychotherapy Research

For prescribing psychiatrists who want to offer treatment alternatives to patients who prefer to avoid medication, the evidence is clear that psychotherapy is an effective choice. Even in cases in which medication is accepted, the evidence suggests that psychotherapy may significantly improve patient outcomes.


Georg Northoff, MD, PhD

Latest:

Psychopathology and Pathophysiology of Depression

Is depression a systemic disorder of oneself and the brain’s intrinsic activity?


George Dawson, MD

Latest:

Epistemic Humility in Psychiatry: Why We Need More Montaigne and Less Savonarola

Delve into the imperative of embracing epistemic humility in psychiatry.


George E. Woody, MD

Latest:

Addiction, AIDS, and NIDA’s Overseas Program

A report on substance abuse and HIV research around the world.


George Ferenczi, MD, MBA

Latest:

'I Feel I Am Successful When…'

Gastroenterologist George Ferenczi escaped the Iron Curtain as a boy. Now he tries to justify his luck, and life.


George Hutton, MD

Latest:

Multiple Sclerosis: MRI in Diagnosis, Management, and Monitoring

MRI has provided important insights into the pathophysiology of multiple sclerosis (MS).1 However, conventional MRI scans furnish only gross estimates of the nature and extent of tissue damage associated with MS,2 and the data correlate poorly with measures of concurrent disability in patients.


George I. Papakostas, MD

Latest:

Treatment-Resistant Major Depressive Disorder: New Developments in 2006

Despite the progressive increase in the number of available antidepressants, many patients with depression continue to be symptomatic.


George Loeffler, MD

Latest:

A First-Episode Psychosis Treatment Program: “The Disease Doesn’t Define Me”

The Psychiatric Transition Program at the Naval Medical Center in San Diego is a specialized first-episode psychosis program that provides coordinated specialty care to active-duty service members with serious mental illness.


George Mckinley, MD

Latest:

Frontolobular Cystic Mass and Hydrocephalus in Woman With Headache and Lethargy

A previously healthy 35-year-old woman was admitted to a New York City hospital after presenting to the emergency department (ED) with a 10- to 14-day history of generalized weakness, progressive frontal headache, and lethargy. She immigrated to Brooklyn, New York, from urban Haiti 9 years previously and had not returned to Haiti since. She denied any recent travel elsewhere and had no pets. An HIV antibody test, performed 4 months before ED presentation, was negative.


George Mecouch, DO

Latest:

The Arms of Ivy Welcome Her

With the help of psychotherapy, something from the deep unconscious helped cure her depression, forge her character, and guide her to a sense of peace.


George Michael Viola, MD

Latest:

Frontolobular Cystic Mass and Hydrocephalus in Woman With Headache and Lethargy

A previously healthy 35-year-old woman was admitted to a New York City hospital after presenting to the emergency department (ED) with a 10- to 14-day history of generalized weakness, progressive frontal headache, and lethargy. She immigrated to Brooklyn, New York, from urban Haiti 9 years previously and had not returned to Haiti since. She denied any recent travel elsewhere and had no pets. An HIV antibody test, performed 4 months before ED presentation, was negative.


George Simpson, MD

Latest:

Treatment-Resistant Schizophrenia: Making the Determination

Several confounding factors need to be taken into account before labeling a patient as treatment-resistant. What options are available for treating a patient with schizophrenia who has been diagnosed as such?


George Stricker, PhD

Latest:

An Introduction to Psychotherapy Integration

There are three types of integration practiced by psychotherapists: Common Factors, Assimilative Integration and Theoretical Integration. How do they differ from each other, and how does psychotherapy integration differ from an eclectic approach to therapy?


Georgeann Neuzil, MS

Latest:

Adaptation and Implementation of the Integrated Dual Diagnosis Treatment Model Into a Psychiatric Inpatient Facility: A 12-Year Perspective

As early as the 1970s, researchers and practitioners became increasingly aware of the necessity for services that would address the varied needs and treatment implications for consumers with the co-occurring disorders of substance abuse and mental illness. High percentages of consumers in substance abuse treatment centers were identified with mental illness disorders, and consumers admitted to psychiatric facilities often were identified as having additional substance use disorders.


Gerald A. Maguire, MD

Latest:

Pseudobulbar Affect Versus Depression: Issues in Diagnosis and Treatment

The most challenging aspect of pseudobulbar affect is differentiating it from depression. Episodes of uncontrollable, sudden, and even inappropriate emotions may point to neurologic or psychiatric conditions.


Gerald O'Malley, DO

Latest:

Rika the Riveter

My wife, Rika, has completed six years of excruciating residency, passed the board exam the first time that she took it and is completing a similarly demanding medical toxicology fellowship now. She is raising our two beautiful children, works in a dangerous, hostile, challenging inner city ER, teaches, does research, refuses to hire a housekeeper yet keeps the house running like clockwork and puts up with me and all my crap.


Gerald Schneiderman, MD

Latest:

Sixty-Five Years After World War II: A Family Secret

The Holocaust is well known and has been well researched. The purpose of this study was to evaluate persons 65 years after the Holocaust who remained in Poland and discovered the “secret” of their Jewish ancestry, despite not being raised as Jews.


Gerald Valentine, MD

Latest:

MDMA and Ecstasy

Although there are numerous media accounts of the detrimental effects of the drug Ecstasy, there may also be some clinical uses in the treatment of PTSD. The U.S. Food and Drug Administration has approved the first-ever clinical trial of MDMA since it was banned in 1988. An expert in the field discusses what psychiatrists need to know about the popular "rave" drug and the compound's use as a therapeutic tool.


Gerald W. Keister

Latest:

The Huntington's Disease Society of America: Dedicated to Education and Care

Huntington disease (HD) is a devastating hereditary, degenerative brain disorder for which there is, at present, no effective treatment or cure. More than a quarter of a million Americans have HD or are at risk for the disease because of potential genetic transmission. The disease slowly diminishes the affected person's ability to walk, think, talk, and reason. As it progresses, concentration and short-term memory diminish and involuntary movements of the head, trunk, and limbs increase.


Gerard Sanacora, MD, PhD

Latest:

ECT and Ketamine/Esketamine: Guiding Clinical Practice

ECT: a gold-standard treatment for major depressive disorder. Ketamine/esketamine: a newer therapeutic option. This ACNP 2023 Annual Meeting session took a deeper look.


Gerhard Gründer, MD

Latest:

Psychotropic Drugs: Brain and Plasma Pharmacokinetics and the Therapeutic Window

Administering drug dosages that are clinically effective while causing minimal side effects is a challenge for physicians. The latest data on antipsychotics, antidepressants, and other psychotropic drugs in relation to brain occupancy and plasma levels are reviewed here.


Giancarlo Dimaggio, MD

Latest:

10 Things to Know About Narcissistic Personality Disorder

Lack of empathy is a commonly known feature of narcissistic personality disorder. Relationships are typically shallow and difficult to maintain. What are some other features of NPD? More in this case presentation.

© 2024 MJH Life Sciences

All rights reserved.